Literature DB >> 28540836

Vocal cord paresis following single-session high intensity focused ablation (HIFU) treatment of benign thyroid nodules: incidence and risk factors.

Brian H H Lang1, Yu-Cho Woo2, Keith Wan-Hang Chiu3.   

Abstract

BACKGROUND: Vocal cord paresis (VCP) may occur following high intensity focused ultrasound (HIFU) of thyroid nodules. We hypothesised its occurrence relates to the distance of the focus point (FP) of the HIFU beams from the recurrent laryngeal nerve (RLN) and the thermal power that this point received. Their relationships were examined.
METHODS: One hundred and three patients who underwent HIFU for symptomatic benign thyroid nodule from October 2015 to March 2017 were analysed. All treatment images were captured and were later watched by 2 reviewers to identify three FPs closest to the tracheoesophageal groove (TEG) on transverse sonographic view. TEG was taken as the RLN position. After identifying these FPs, their distance (mm) from the TEG, thermal power (W) used and depth from skin (mm) were recorded. These parameters were compared between those with and without VCP. VCP was defined as a cord with reduced or no movement.
RESULTS: Four (3.9%) patients suffered from a unilateral VCP afterwards but they all recovered fully within 6 weeks. There were no significant differences in baseline characteristics and treatment efficacy between the two groups. The distance from TEG (OR = 1.706, 95%CI = 1.001 to 2.915, p = 0.050) was the only significant factor for VCP. None of the other variables including thermal power were significant.
CONCLUSIONS: The incidence of VCP was 3.9% (4/103) and they completely recovered within 6 weeks. The distance between the FP and the TEG was the only related factor for VCP. The safe distance between FP and TEG should be ≥1.1 cm.

Entities:  

Keywords:  Focused ultrasound; benign thyroid nodule; recurrent laryngeal nerve; thermal ablation; vocal cord palsy

Mesh:

Year:  2017        PMID: 28540836     DOI: 10.1080/02656736.2017.1328130

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  9 in total

1.  Significance of hyperechoic marks observed during high-intensity focused ultrasound (HIFU) ablation of benign thyroid nodules.

Authors:  Brian H H Lang; Yu-Cho Woo; Keith Wan-Hang Chiu
Journal:  Eur Radiol       Date:  2018-01-08       Impact factor: 5.315

2.  Two-year outcomes of single-session high-intensity focused ultrasound (HIFU) treatment in persistent or relapsed Graves' disease.

Authors:  Brian Hung-Hin Lang; Yu-Cho Woo; Keith Wan-Hang Chiu
Journal:  Eur Radiol       Date:  2019-06-17       Impact factor: 5.315

3.  High-intensity focused ultrasound (HIFU) therapy for benign thyroid nodules without anesthesia or sedation.

Authors:  Pierpaolo Trimboli; Fabiano Bini; Franco Marinozzi; Jung Hwan Baek; Luca Giovanella
Journal:  Endocrine       Date:  2018-02-16       Impact factor: 3.633

4.  2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules.

Authors:  Enrico Papini; Hervé Monpeyssen; Andrea Frasoldati; Laszlo Hegedüs
Journal:  Eur Thyroid J       Date:  2020-06-08

5.  Sequential high intensity focused ultrasound (HIFU) ablation in the treatment of benign multinodular goitre: an observational retrospective study.

Authors:  Brian H H Lang; Yu-Cho Woo; Keith Wan-Hang Chiu
Journal:  Eur Radiol       Date:  2018-03-19       Impact factor: 5.315

6.  Combining high-intensity focused ultrasound (HIFU) ablation with percutaneous ethanol injection (PEI) in the treatment of benign thyroid nodules.

Authors:  Brian H H Lang; Yu-Cho Woo; Keith Wan-Hang Chiu
Journal:  Eur Radiol       Date:  2020-09-24       Impact factor: 5.315

Review 7.  The efficacy and safety of high-intensity focused ultrasound ablation of benign thyroid nodules.

Authors:  Brian H Lang; Arnold L H Wu
Journal:  Ultrasonography       Date:  2017-10-10

8.  High-intensity focused ultrasound ablation as a treatment for benign thyroid diseases: the present and future.

Authors:  Nicholas Kotewall; Brian H H Lang
Journal:  Ultrasonography       Date:  2018-11-09

Review 9.  Focused Ultrasound (FUS) for Chronic Pain Management: Approved and Potential Applications.

Authors:  Lazzaro di Biase; Emma Falato; Maria Letizia Caminiti; Pasquale Maria Pecoraro; Flavia Narducci; Vincenzo Di Lazzaro
Journal:  Neurol Res Int       Date:  2021-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.